Flow Of Scientific Progress Creates Wave Of New Journals

The world of scientific publishing never ceases to change. Each year, while some journals go out of business, new ones appear, their publishers intent on filling a void in a particular subject's literature or augmenting the existing publications in that field. In addition, journal titles may change or publications may merge to create new journals with completely different titles. In 1989, the Philadelphia-based Institute for Scientific Information (ISI) added more than 100 titles to its existi

Written byAbigail Grissom
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In 1989, the Philadelphia-based Institute for Scientific Information (ISI) added more than 100 titles to its existing Science Citation Index (SCI) coverage of 3,170 journals in the physical and life sciences and other technical areas such as air and waste management and fluid dynamics. Last year, however, two fields alone--neuroscience and pharmacy/pharmacology--contributed more than 18 percent of the new titles.

The accompanying Table 1 lists the neuroscience and pharmacy/ pharmacology titles added to SCI in 1989. Some publications, such as the Journal of Neural Transmission (General Section and Parkinson's Disease and Dementia Section), Molecular and Chemical Neuropathology, Critical Reviews in Neurobiology, Pharmacological Research, and DICP--The Annals of Pharmacotherapy are not new journals, but already established publications with altered titles. Another journal, Acta Pharmaceutica Nordica, originated in 1938 but over the years has incorporated several existing periodicals while retaining its original title.

Other journals on the list are new only to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies